期刊文献+

头孢噻呋钠-壳聚糖纳米粒的制备及相关性质的研究 被引量:3

Preparation and characterization of ceftiofur sodium-chitosan nanoparticles
原文传递
导出
摘要 为了延长头孢噻呋钠的作用时间,采用离子交联法制备头孢噻呋钠-壳聚糖纳米粒,研究其形态、粒径、载药量、包封率和体外释药特性。结果显示,经优化工艺所得的纳米粒形态规整,近圆形,平均粒径为179.4±39.5nm,平均包封率为84.31%±2.53%,平均载药量为6.69%±0.18%。体外释放试验表明,原料药在放入释放介质后第4小时释放率达到90%以上,而纳米粒在此时药物仅释放60%。结果表明,该纳米粒制备工艺可行,对头孢噻呋钠具有明显的缓释效果。 To prolong the action time of ceftiofur sodium, ceftiofur sodium-chitosan nanoparticle(CNP) were prepared by ionic crosslinking method. Morphology, particle size and distribution, encapsulation efficiency and drug loading rate were investigated. In result, the appearance of prepared CNP was regular with the diameter being of 179.4±39.5 nm. The encapsulation efficiency and drug-loading rate were 84.31% ±2.53 % and 6.69 %±0.18 % respectively. The in vitro release experiment showed that the ceftiofur sodium was released above 90% at 4 h post-treatment,meanwhile only 60% was released from CNP. In conclusion, the CNP preparation procedure is feasible and CNP have obvious sustained-release effect.
出处 《中国兽医科学》 CAS CSCD 北大核心 2012年第6期637-641,共5页 Chinese Veterinary Science
基金 教育部"长江学者和创新团队发展计划"创新团队项目(IRT0848)
关键词 头孢噻呋钠 壳聚糖 纳米粒 质量评价 ceftiofur sodium chitosan nanoparticle quality evaluation
  • 引文网络
  • 相关文献

参考文献5

二级参考文献21

  • 1付春梅,刘三康,李章万,钱广生.穿琥宁原料药及其注射液的有关物质检查和含量测定方法研究[J].药物分析杂志,2005,25(2):157-159. 被引量:8
  • 2王琳,蔡宝昌,李伟东,邓旭坤.马钱子碱长循环脂质体的制备和质量评价[J].中国药学杂志,2006,41(18):1397-1400. 被引量:24
  • 3董方田 陈有信 张承芬 见:张承芬 主编.玻璃体疾患[A].见:张承芬,主编.眼底病学.第1版[C].北京:人民卫生出版社,1998.357-358. 被引量:2
  • 4Rachal WF,Burton TC.Changing concepts of failures after retinal detachment surgery.Arch Ophthalmol,1979,97:480-483 被引量:1
  • 5Boisdron M,Menei PH,Benoit JP.Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancerdrug carriers.J Pharm Pharmacol,1995,47:108-111 被引量:1
  • 6Li JK,Wang N,Wu XS.A novel biodegradable system based ongelatin nanoparticles and peptide drug delivery.J Pharm Sci,1997,86:891-894 被引量:1
  • 7Prior S,Gamazo C,Irache JM.Gentamycin encapsulation in PLA/PLGA microspheres in view of treating Brucella infection.International Journal of Pharmaceutics,2000,196:115-118 被引量:1
  • 8Stern WH,Lewis GP,Erickson PA,et al.Fluorouracil therapy forproliferative vitreoretinopathy after vitrectomy.Am J Ophthalmol,1983,96:33-42 被引量:1
  • 9Anas El Aneed.An overview of current delivery systems in cancer gene therapy[J].Journal of Controlled Release ,2004,94:1 被引量:1
  • 10Curotto E,Aros F.Quantitative determination of chitosan and the percentage of free amino group[J].Analytical Biochemistry,1993, 211(2):240 被引量:1

共引文献95

同被引文献35

引证文献3

二级引证文献10

;
使用帮助 返回顶部